I had the privilege of working with Professor Graham MacGregor from 1996 until his passing. I first joined Graham’s team at the Blood Pressure Unit, St George’s University of London, as a volunteer. At that time, I had just arrived from China, and my spoken English was not good—I lost count of how many times we misunderstood each other. In spite of this, Graham believed in me, and his encouragement gave me the confidence to pursue a PhD. After completing my doctorate, I continued working with Graham, focusing mainly on salt reduction to prevent high blood pressure and cardiovascular disease. In 2009, our team moved to Queen Mary University of London.
Over nearly 30 years of working closely with Graham, I learned so much from him. My career journey—from volunteer to Professor of Global Health Research—would not have been possible without his continued guidance and strong support. He was a true inspiration to me and to our whole team.
Graham was the pioneer and a global leader in salt reduction. In the early 1980s, he carried out the first well-controlled double-blind trial showing that a modest reduction in salt intake significantly lowers blood pressure, and in later studies showing a clear dose-response relationship between salt intake and blood pressure. Subsequently, many other studies including our own systematic review and meta-analyses demonstrated that the totality of the evidence for reducing population salt intake was very strong, forming the key evidence base for salt reduction campaigns worldwide.
Graham had a unique ability to push governments and the food industry to act. He was ruthless, fearless, and persistent in persuading food manufacturers to gradually reduce the large and unnecessary amounts of salt added to our foods. He championed a target-based approach, setting progressively lower salt targets for more than 80 food categories. This strategy, adopted by the Food Standards Agency, led to substantial reductions in the salt content of foods, resulting in decreases in population salt intake, blood pressure, and cardiovascular disease mortality in the UK. Graham went on to help many other countries, including Malaysia and China, reduce their salt intake. His work has undoubtedly prevented hundreds of thousands of people from suffering or dying from stroke, heart disease, and heart failure each year.
Although Graham was widely recognised for his public health advocacy, he was also an outstanding clinical scientist. He was meticulous at every stage of research—from study design and protocol implementation to data analysis—and he expected the same from his team. For example, in all of our studies, data had to be carefully checked, double-checked, and independently verified. It was this rigour and thoroughness that made our research a trusted source of evidence, particularly at a time when methodologically flawed studies caused controversy, impeding global efforts to reduce salt intake.
Graham was often described as a thorn in the side of the food industry and government because of his unwavering and uncompromising approach to reducing salt and sugar. Yet on a personal level, he was very kind and always willing to help our team whenever we were in need. From my own experience, in 2001, when my husband became seriously ill and doctors could not determine the cause, it was Graham who helped, eventually leading to the right diagnosis. With proper treatment, my husband made a remarkable recovery. I will forever be indebted to Graham for saving my husband’s life and for the countless ways he supported our colleagues. All of us will miss him deeply.
Finally, I would like to say to Graham: Dear Prof, rest in peace. Your legacy will continue. The team you trained at Action on Salt and Sugar has promised to redouble its efforts to reduce salt and sugar consumption, saving lives in the UK and around the world.